尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Pimstone Simon N., 首席执行官. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Aggregated, 7 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €2.8m. History available since 24 May 2021. The latest transaction was filed on 30 May 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Simon N. Pimstone is the CEO and Director at Xenon Pharmaceuticals Inc. He leads the company in the pharmaceutical sector, focusing on developing innovative treatments. His leadership is essential in guiding the strategy and growth of the company.